It’s a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.
When asked if he would share the COVID-19 vaccine recipes with developing nations, the tech mogul categorically refused, much to the shock of everyone who believed Gates prioritized saving lives over making profits.
“There’s only so many vaccine factories in the world and people are very serious about the safety… Moving a vaccine, say, from a factory into a factory in India, it’s novel, it’s only because of our grants and expertise that can happen at all,” said Gates.
He contends there are limited vaccine factories in the world, and that transferring manufacturing technology can’t be done without American “grants” and “expertise”.
A report by Australian Fair Trade & Investment Network Ltd (AFTINET) reveals how the Bill and Melinda Gates Foundation’s involvement in the partnership between the University Oxford and AstraZeneca prevented the vaccine from having an open distribution model.
The Gates Foundation declared more than $250 million in vaccine investments through regulatory filings. The foundation’s $40 million-worth stake in CureVac alone has delivered profits to the tune of tens of millions of dollars.